Development of drugs on the basis of high-polymeric double-stranded RNA for antiviral and antitumor therapy

   
Danilenko E.D.1 , Belkina A.O.1, Sysoeva G.M.1

1. Institute of Medical Biotechnology, State Research Center of Virology and Biotechnology “Vector”, Berdsk, Russia
Section: Review
DOI: 10.18097/PBMC20196504277      PubMed Id: 31436169
Year: 2019  Volume: 65  Issue: 4  Pages: 277-293
The review summarizes literature data on the development of drugs based on natural and synthetic high-polymeric double-stranded RNA, and their antiviral, immunoadjuvant and antitumor properties. Special attention is paid to cell receptors responding to exogenous dsRNA, the paths of dsRNA-dependent antiviral reaction, ability of dsRNA to inhibit growth and induce apoptosis ofmalignant cells. It has been shown that enhancing the innate immune response with dsRNA can be an effective component in improving methods for treating and preventing infectious and cancer diseases. The further use of dsRNA for the correction of pathological processes of different origin is discussed
Download PDF:  
Keywords: double-stranded RNA, interferon inducers, immunomodulators, antitumor and antiviral properties
Citation:

Danilenko, E. D., Belkina, A. O., Sysoeva, G. M. (2019). Development of drugs on the basis of high-polymeric double-stranded RNA for antiviral and antitumor therapy. Biomeditsinskaya Khimiya, 65(4), 277-293.
This paper is also available as the English translation: 10.1134/S1990750819040036
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)